Latest Commercialization News

Orthocell has reached a significant milestone with 100 units of its nerve repair product Remplir™ sold in the US, signaling accelerating adoption in a $1.6 billion market. The company’s strategic medical education and distributor network are driving momentum ahead of further hospital approvals.

Mount Ridley Mines has locked in nearly $1.8 million through a fully underwritten exercise of expiring unlisted options, ensuring financial backing for its Mount Ridley Project exploration and metallurgical programs.

Memphasys Limited’s partner International Technical Legacy has placed an early order for 500 Felix™ cartridges ahead of anticipated CE Mark approval, signalling strong clinic demand and validating the company’s direct-selling strategy in the Middle East.

Estrella Resources has reported further high-grade manganese intersections at its Ira Miri Prospect, alongside completion of extensive drilling at the Werumata Limestone Project in Timor-Leste, highlighting promising resource potential.

ABx Group’s preliminary column leach tests reveal exceptional extraction rates of heavy rare earths from its Deep Leads project, underscoring the potential for cost-effective heap leaching and accelerated commercial production.

St George Mining reports its thickest and highest-grade rare earth and niobium intercept to date at the Araxá Project, signaling a potential major resource expansion in Brazil.

Zeotech Limited has completed a significant test pit at its Toondoon Kaolin Project, producing over 2,300 tonnes of kaolin and progressing key approvals to fast-track mining and product development.

BlinkLab Limited has appointed its Co-Founder and CEO, Dr Henk-Jan Boele, as Managing Director to steer the company through its pivotal FDA 510(k) trial for its autism diagnostic technology. The move coincides with key board changes and signals a strategic shift as BlinkLab prepares for early commercialisation.

HealthCo Healthcare & Wellness REIT confirms full rent payment from Healthscope and has conditional agreements with alternative tenants for its hospital portfolio, while suspending its December quarter distribution to preserve liquidity.

Actinogen Medical has finalized enrollment and begun treatment of all 246 participants in its XanaMIA Phase 2b/3 Alzheimer’s trial, with topline results expected in November 2026. The oral drug Xanamem targets brain cortisol to potentially slow disease progression.

Felix Gold Limited reports strong continuity of high-grade antimony mineralisation at its NW Array prospect in Alaska, while engaging Worley to accelerate processing pathways. The company targets near-term bulk sampling and production aligned with US strategic supply needs.

SportsHero Limited has secured its largest-ever cash receipt of approximately A$530,000 following the successful rollout of its iGV.Com Game Pass in the Philippines, marking a pivotal step in its commercial journey.